🕵️ Applied Therapeutics, Inc. ($APLT)
SEC insider & ownership activity, last 12 months · CIK 1697532 · every row links its SEC filing
Over the last 12 months insiders sold $5K with no open-market buying against it. Stacy J. Kanter sold $5K in discretionary trades (Dec). T. ROWE Price Investment Management, Inc. added 13.2% → 14.9%. One red-flag 8-K in the window: Delisting notice (3.01), Feb 3, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $5K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Stacy J. Kanter | 0 | – | 1 | $5K | Dec 16, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| T. ROWE Price Investment Management, Inc. | 14.9% | 13G | Nov 14, 2025 | filing ↗ | |
| Alyeska Investment Group, L.P. | 5.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Alyeska Fund GP, LLC | 5.8% | 13G | Feb 14, 2025 | filing ↗ | |
| Anand Parekh | 5.8% | 13G | Feb 14, 2025 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Stacy J. Kanter | $9K | Dec 16, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Acquisition or disposition (2.01) | Feb 3, 2026 | filing ↗ |
| Delisting notice (3.01) | Feb 3, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Feb 3, 2026 | filing ↗ |
| Change of control (5.01) | Feb 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 3, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 11, 2025 | filing ↗ |
| New financial obligation (2.03) | Dec 11, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 11, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 11, 2025 | filing ↗ |
| Other events (8.01) | Nov 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 20, 2025 | filing ↗ |
| Earnings (2.02) | Nov 9, 2025 | filing ↗ |
| Officer/director changes (5.02) | Nov 9, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 9, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 29, 2025 | filing ↗ |
| Other events (8.01) | Aug 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |
| Other events (8.01) | Aug 13, 2025 | filing ↗ |
| Earnings (2.02) | Aug 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2025 | filing ↗ |
| Earnings (2.02) | Aug 11, 2025 | filing ↗ |
| Other events (8.01) | Aug 11, 2025 | filing ↗ |